14,474 results found

This survey has been provided by the Fox Rothschild Administrative Law; Government Relations Practice as a quick reference to relevant laws and statutes governing marijuana usage in the United States.

The November issue of Squire Patton Boggs Bio/Pharma Beat is now available. Our monthly newsletter reports on important patent law developments in biotech,...

In recent issues of the Federal Register, FDA announced determinations of the regulatory review periods for extension of three drug patents.

The use of marijuana for medicinal purposes has been legalized in 23 states and Washington D.C., and recreational use has been legalized in Alaska, Colorado, Oregon, Washington, DC and Washington state.

The Board may soon rule on whether the Petitions for Inter Partes Review filed by the Coalition for Affordable Drugs VI, LLC against certain patents owned by Celgene Corporation amount to an abuse of process deserving of sanctions.

GlaxoSmithKline (GSK) and Teva settled their almost decade-long skinny label dispute after landing, one last time, back in the District of Delaware where Teva had sought a new trial until yesterday when the Court granted the parties’ Joint Stipulation to Dismiss (Case No. 14-cv-878) filed on Friday.

They discuss the precedent set by other cases in this realm and key takeaways about the operation of the regulatory compliance defense in the context of Orange Book antitrust cases in light of recent litigation.

The Bureau of Industry and Security (BIS) is requesting public comments on the effectiveness of its licensing procedures for the export of agricultural commodities to Cuba.

Ocean Spray Cranberries Inc. has agreed to pay $5.4 million to settle claims that it misleadingly advertised its beverages as lacking artificial flavors despite containing malic avid.

The court overseeing statewide opioid litigation in New York recently made a ruling regarding the manner in which a March 2020 trial will proceed.

In a dispute between rival pharmaceutical manufacturers, the Second Circuit affirmed summary judgment for defendant Acorda Therapeutics, adopting the rule that "representations commensurate with information in an FDA label...

In 2025, the restaurant industry is expected to face significant challenges due to macroeconomic, trade, and immigration uncertainties.

Our firm's LSHI Group reported on an announcement by the Food and Drug Administration (FDA) last week, asking for public input on a proposed research study concerning whether the risks presented in direct-to-consumer (DTC) prescription drug ads should be limited solely to risks that are considered "serious and actionable."

The U.S. pet industry has reached $158 billion in spending, driven by strong demand in food, treats, and veterinary care. As organizations face increasing operational disruptions from cyber threats...

The leaders of the Visegrád Group plan to adopt a joint declaration summing up the process of integration.

The new aid package, which will last until June 30, 2016, aims to ease market pressures for the main groups of fruits and vegetables that were previously exported to Russia.

EFSA will use the Commission's advice to develop guidance on data requirements for applications for the safety assessment of substances in food contact materials.